Perrigo Names Head Of Regulatory Review

Article

Perrigo appoints Keith Webber as head of regulatory review.

Perrigo has appointed Keith Webber as head of regulatory review, effective Oct. 21, 2013 with responsibility for advancing the approval of all of Perrigo's consumer healthcare and prescription pharmaceutical regulatory applications pending with FDA, providing guidance on scientific and regulatory strategy for pipeline products, and advancing the quality of new regulatory applications.

Webber previously was Acting Director of the Office of the FDA's Pharmaceutical Science in the Center for Drug Evaluation and Research.

Source: Perrigo

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content